All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q3 report for Pierre Fabre Pharmaceuticals Inc. on October 16, 2026, reporting no lobbying activity.

Lobbying for Pierre Fabre Pharmaceuticals Inc. · Pharmaceutical manufacturer

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for PIERRE FABRE PHARMACEUTICALS INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Pierre Fabre Pharmaceuticals Inc. has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 16, 2026.

Filing · LD-2 quarterly report Q3 reportNo activity

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 16, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Official filing document

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.